Clinical Trial Update: URO-BCG-4 : Bladder Tumors Immunotherapy

View source ↗

Summary

This is a completed clinical trial update for URO-BCG-4 investigating bladder tumor immunotherapy with intravesical Bacillus Calmette-Guérin (BCG) in bladder ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) (Bacillus Calmette-Guérin)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Bladder Cancer | Status: COMPLETED